Rebound Hypercalcaemia Timing is Associated with Cumulative Weight-Based Denosumab Dose for Central Giant Cell Granuloma Treatment in Children Despite a Dose Weaning Regimen
DOI:
10.2139/ssrn.5152332
Publication Date:
2025-03-04T01:15:13Z
AUTHORS (11)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....